WO2001004142A3 - Nouveaux composes - Google Patents

Nouveaux composes Download PDF

Info

Publication number
WO2001004142A3
WO2001004142A3 PCT/EP2000/006253 EP0006253W WO0104142A3 WO 2001004142 A3 WO2001004142 A3 WO 2001004142A3 EP 0006253 W EP0006253 W EP 0006253W WO 0104142 A3 WO0104142 A3 WO 0104142A3
Authority
WO
WIPO (PCT)
Prior art keywords
neurotransmitter transporter
polypeptides
polynucleotides
disclosed
methods
Prior art date
Application number
PCT/EP2000/006253
Other languages
English (en)
Other versions
WO2001004142A2 (fr
Inventor
Hugh Jonathan Herdon
Joanne Rachel Evans
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of WO2001004142A2 publication Critical patent/WO2001004142A2/fr
Publication of WO2001004142A3 publication Critical patent/WO2001004142A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Cette invention concerne des polypeptides et des polynucléotides GC42 ainsi que des procédés d'obtention desdits polypeptides au moyen de techniques recombinantes. L'invention porte également sur l'utilisation de polypeptides et de polynucléotides GC42 dans le cadre d'essais diagnostiques.
PCT/EP2000/006253 1999-07-08 2000-07-04 Nouveaux composes WO2001004142A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9916076.4 1999-07-08
GBGB9916076.4A GB9916076D0 (en) 1999-07-08 1999-07-08 Novel compounds

Publications (2)

Publication Number Publication Date
WO2001004142A2 WO2001004142A2 (fr) 2001-01-18
WO2001004142A3 true WO2001004142A3 (fr) 2001-05-17

Family

ID=10856918

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/006253 WO2001004142A2 (fr) 1999-07-08 2000-07-04 Nouveaux composes

Country Status (2)

Country Link
GB (1) GB9916076D0 (fr)
WO (1) WO2001004142A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1609504A4 (fr) * 2003-03-28 2010-07-21 Nissan Chemical Ind Ltd Agents bloquant les canaux calciques de type t

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756348A (en) * 1991-11-12 1998-05-26 Synaptic Pharmaceutical Corporation DNA encoding a glycine transporter and uses thereof
US5824486A (en) * 1996-05-31 1998-10-20 Allelix Neuroscience Inc. Glycine transporter-transfected cells and uses thereof
WO1998046619A1 (fr) * 1997-04-11 1998-10-22 Allelix Neuroscience Inc. Transporteur de la glycine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756348A (en) * 1991-11-12 1998-05-26 Synaptic Pharmaceutical Corporation DNA encoding a glycine transporter and uses thereof
US5824486A (en) * 1996-05-31 1998-10-20 Allelix Neuroscience Inc. Glycine transporter-transfected cells and uses thereof
WO1998046619A1 (fr) * 1997-04-11 1998-10-22 Allelix Neuroscience Inc. Transporteur de la glycine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GUASTELLA ET AL.: "Cloning, expression, and localization of a rat brain high-affinity glycine transporter", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE USA, vol. 89, 1992, pages 7189 - 7193, XP002158328 *
KIM K -M ET AL: "CLONING OF THE HUMAN GLYCINE TRANSPORTER TYPE 1: MOLECULAR AND PHARMACOLOGICAL CHARACTERIZATION OF NOVEL ISOFORM VARIANTS AND CHROMOSOMAL LOCALIZATION OF THE GENE IN THE HUMAN AND MOUSE GENOMES", MOLECULAR PHARMACOLOGY,US,BALTIMORE, MD, vol. 45, 1994, pages 608 - 617, XP002911694, ISSN: 0026-895X *

Also Published As

Publication number Publication date
WO2001004142A2 (fr) 2001-01-18
GB9916076D0 (en) 1999-09-08

Similar Documents

Publication Publication Date Title
EP1001023A3 (fr) Frizzled-4, un possible récepteur pour Wnt
EP0939124A3 (fr) Séquences de la MBGP1
WO1999035266A3 (fr) Urotensine humaine ii
WO2001004141A3 (fr) Seripancrine
EP0943684A3 (fr) Polypeptides et polynucléotides ressemblant à frizzled
WO2001083744A3 (fr) Nouvelle proteine echangeuse sodium-calcium
EP0879888A3 (fr) Polypeptides patched-2 et polynucléotides et leurs procédés de fabrication
WO2001032864A3 (fr) Nouveaux polypeptides de type gpcr_kd5 et sequences d'adn correspondantes
EP0885959A3 (fr) Protéine Wnt-5b humaine
WO2001004142A3 (fr) Nouveaux composes
WO2001019854A3 (fr) Nouveaux composes
EP0887416A3 (fr) Enzyme AFC1 humaine
WO1999011783A3 (fr) Polypeptides de boite t
EP0937777A3 (fr) Récepteurs de GABA et leurs utilisations
WO2001055338A3 (fr) Recepteur 7tm de (axor51)
WO2002014355A3 (fr) Nouvelles protéines mekk
EP0890646A3 (fr) HE2NW40 Sérine protéase
EP0875570A3 (fr) Polypeptides neurodégénératives HHPDZ65
EP0939123A3 (fr) SBPERR4, analogue du récepteur oestrogénique
EP0882791A3 (fr) WNT-11 Polypeptides
WO2001079269A3 (fr) Nouvelle proteine 4 de liaison des lipides
WO2001083768A3 (fr) Nouvelle serine-threonine kinase
WO2001062779A3 (fr) Nouveau facteur de transcription carp-2
WO2001055428A3 (fr) Nouveaux composes
WO2001038348A3 (fr) Recepteur htogh35 couple a la proteine g

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 509751

Kind code of ref document: A

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase